Stay updated on Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedVersion revision updated from v3.6.3 to v3.6.4, indicating a site maintenance update. This reflects an under-the-hood software update across the pages rather than changes to the study content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a new revision of the page was published.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer release of the page. This update typically includes maintenance or minor fixes rather than changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now shows recruitment is closed and adds reader guidance sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading formatting was updated and the revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check61 days agoChange DetectedThe page now displays a newer site revision label (v3.5.5) replacing the previous v3.5.4. This reflects a software release or deployment and does not alter the study details presented.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, representing a minor site update. This change does not modify the study content, results, or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.